PolyPeptide Shares Surge Amid Takeover Interest From EQT, KKR

PolyPeptide Group AG shares hit the highest level in more than three years, after people with knowledge of the matter said the Swiss contract drugmaker is attracting private equity takeover interest.

Shares of PolyPeptide jumped as much as 16% in early trading Monday, the biggest intraday gain since November 2024. They were up 10% at 10:46 a.m. in Zurich, giving the company a market value of about 1.2 billion Swiss francs ($1.5 billion) and putting it on track to close at the highest level since December 2022.

EQT AB, KKR & Co. and Advent are among suitors that have ...